New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
Patients are flocking to the first new obesity medicine to reach the market in years, boosting returns for drugmaker Novo Nordisk A/S.
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in…
Read More...
Read More...